Redwood City, CA – According to filings with the U.S. Securities and Exchange Commission, Procept BioRobotics is raising $76,982,192.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Reza Zadno played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Procept BioRobotics

Based in Silicon Valley, PROCEPT BioRobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. The AQUABEAM Robotic System delivering Aquablation therapy, is the world’s first commercially available minimally invasive surgical robot providing autonomous tissue removal to safely and effectively treat BPH.

To learn more about Procept BioRobotics, visit http://www.procept-biorobotics.com/

Contact:
Reza Zadno, Chief Executive Officer
650-232-7200
https://www.linkedin.com/in/reza-zadno-3a459195/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved